{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:16:07Z","timestamp":1761920167606,"version":"3.37.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40273-016-0435-7","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T08:59:58Z","timestamp":1469523598000},"page":"1255-1265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis: Results from a Contingent Valuation Study"],"prefix":"10.1007","volume":"34","author":[{"given":"Pei-Jung","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cayla J.","family":"Saret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen A.","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"issue":"2","key":"435_CR1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.msard.2013.09.004","volume":"3","author":"JD Campbell","year":"2014","unstructured":"Campbell JD, Ghushchyan V, Brett McQueen R, Cahoon-Metzger S, Livingston T, Vollmer T, et al. Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates. Mult Scler Relat Disord. 2014;3(2):227\u201336.","journal-title":"Mult Scler Relat Disord."},{"issue":"Suppl 5","key":"435_CR2","first-page":"S139","volume":"17","author":"HL Zwibel","year":"2011","unstructured":"Zwibel HL, Smrtka J. Improving quality of life in multiple sclerosis: an unmet need. Am J Manag Care. 2011;17(Suppl 5):S139\u201345.","journal-title":"Am J Manag Care."},{"issue":"3","key":"435_CR3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7224\/1537-2073.2012-053","volume":"15","author":"I Kister","year":"2013","unstructured":"Kister I, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, et al. Natural history of multiple sclerosis symptoms. Int J MS Care. 2013;15(3):146\u201358.","journal-title":"Int J MS Care."},{"issue":"5","key":"435_CR4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.apmr.2013.10.018","volume":"95","author":"S Coote","year":"2014","unstructured":"Coote S, Finlayson M, Sosnoff JJ. Level of mobility limitations and falls status in persons with multiple sclerosis. Arch Phys Med Rehabil. 2014;95(5):862\u20136.","journal-title":"Arch Phys Med Rehabil"},{"key":"435_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2377-12-94","volume":"12","author":"J Pike","year":"2012","unstructured":"Pike J, Jones E, Rajagopalan K, Piercy J, Anderson P. Social and economic burden of walking and mobility problems in multiple sclerosis. BMC Neurol. 2012;12:94.","journal-title":"BMC Neurol."},{"key":"435_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1359105315584837","author":"I Ensari","year":"2015","unstructured":"Ensari I, Adamson BC, Motl RW. Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis. J Health Psychol. 2015. doi: 10.1177\/1359105315584837 .","journal-title":"J Health Psychol"},{"issue":"1","key":"435_CR7","doi-asserted-by":"crossref","first-page":"e54756","DOI":"10.1371\/journal.pone.0054756","volume":"8","author":"CI Coleman","year":"2013","unstructured":"Coleman CI, Sidovar MF, Roberts MS, Kohn C. Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis. PLoS ONE. 2013;8(1):e54756.","journal-title":"PLoS ONE"},{"issue":"2","key":"435_CR8","doi-asserted-by":"crossref","first-page":"e0115541","DOI":"10.1371\/journal.pone.0115541","volume":"10","author":"TJ Weiland","year":"2015","unstructured":"Weiland TJ, Jelinek GA, Marck CH, Hadgkiss EJ, van der Meer DM, Pereira NG, et al. Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS ONE. 2015;10(2):e0115541.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"435_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2005.08.019","volume":"245","author":"MP Amato","year":"2006","unstructured":"Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006;245(1\u20132):41\u20136.","journal-title":"J Neurol Sci"},{"issue":"12","key":"435_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139\u201351.","journal-title":"Lancet Neurol"},{"issue":"12","key":"435_CR11","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1177\/1352458513479840","volume":"19","author":"L Jasse","year":"2013","unstructured":"Jasse L, Vukusic S, Durand-Dubief F, Vartin C, Piras C, Bernard M, et al. Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability. Mult Scler (Houndmills, Basingstoke, England). 2013;19(12):1618\u201326.","journal-title":"Mult Scler (Houndmills, Basingstoke, England)."},{"key":"435_CR12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1743-0003-11-67","volume":"11","author":"I Carpinella","year":"2014","unstructured":"Carpinella I, Cattaneo D, Ferrarin M. Quantitative assessment of upper limb motor function in multiple sclerosis using an instrumented Action Research Arm Test. J Neuroeng Rehabil. 2014;11:67.","journal-title":"J Neuroeng Rehabil."},{"issue":"1","key":"435_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.msard.2014.09.211","volume":"4","author":"AM Bueno","year":"2015","unstructured":"Bueno AM, Sayao AL, Yousefi M, Devonshire V, Traboulsee A, Tremlett H. Health-related quality of life in patients with longstanding \u2018benign multiple sclerosis\u2019. Mult Scler Relat Disord. 2015;4(1):31\u20138.","journal-title":"Mult Scler Relat Disord."},{"issue":"1","key":"435_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/WNO.0000000000000173","volume":"35","author":"S Chahin","year":"2015","unstructured":"Chahin S, Balcer LJ, Miller DM, Zhang A, Galetta SL. Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life. J Neuroophthalmol. 2015;35(1):6\u201311.","journal-title":"J Neuroophthalmol"},{"issue":"1\u20132","key":"435_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2009.11.004","volume":"290","author":"BI Glanz","year":"2010","unstructured":"Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J Neurol Sci. 2010;290(1\u20132):75\u20139.","journal-title":"J Neurol Sci"},{"issue":"4","key":"435_CR16","first-page":"352","volume":"3","author":"JA Opara","year":"2010","unstructured":"Opara JA, Jaracz K, Brola W. Quality of life in multiple sclerosis. J Med Life. 2010;3(4):352\u20138.","journal-title":"J Med Life."},{"issue":"1\u20132","key":"435_CR17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2006.02.018","volume":"246","author":"N Yozbatiran","year":"2006","unstructured":"Yozbatiran N, Baskurt F, Baskurt Z, Ozakbas S, Idiman E. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients. J Neurol Sci. 2006;246(1\u20132):117\u201322.","journal-title":"J Neurol Sci"},{"issue":"4","key":"435_CR18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/joim.12203","volume":"275","author":"AH Cross","year":"2014","unstructured":"Cross AH, Naismith RT. Established and novel disease-modifying treatments in multiple sclerosis. J Intern Med. 2014;275(4):350\u201363.","journal-title":"J Intern Med"},{"issue":"2","key":"435_CR19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00019053-200927020-00005","volume":"27","author":"M Iskedjian","year":"2009","unstructured":"Iskedjian M, Desjardins O, Piwko C, Bereza B, Jaszewski B, Einarson TR. Willingness to pay for a treatment for pain in multiple sclerosis. PharmacoEconomics. 2009;27(2):149\u201358.","journal-title":"PharmacoEconomics."},{"issue":"4","key":"435_CR20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1377\/hlthaff.2011.1301","volume":"31","author":"JA Romley","year":"2012","unstructured":"Romley JA, Sanchez Y, Penrod JR, Goldman DP. Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs. Health Aff (Proj Hope). 2012;31(4):683\u201390.","journal-title":"Health Aff (Proj Hope)."},{"issue":"1","key":"435_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hec.763","volume":"12","author":"N Hanley","year":"2003","unstructured":"Hanley N, Ryan M, Wright R. Estimating the monetary value of health care: lessons from environmental economics. Health Econ. 2003;12(1):3\u201316.","journal-title":"Health Econ"},{"issue":"2","key":"435_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hec.1697","volume":"21","author":"EW Bekker-Grob de","year":"2012","unstructured":"de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145\u201372.","journal-title":"Health Econ"},{"issue":"4","key":"435_CR23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00415-009-0084-2","volume":"256","author":"FR Johnson","year":"2009","unstructured":"Johnson FR, Van Houtven G, Ozdemir S, Hass S, White J, Francis G, et al. Multiple sclerosis patients\u2019 benefit-risk preferences: serious adverse event risks versus treatment efficacy. J Neurol. 2009;256(4):554\u201362.","journal-title":"J Neurol"},{"issue":"2","key":"435_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1756285615622736","volume":"9","author":"C Poulos","year":"2016","unstructured":"Poulos C, Kinter E, Yang JC, Bridges JF, Posner J, Gleissner E, et al. A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany. Ther Adv Neurol Disord. 2016;9(2):95\u2013104.","journal-title":"Ther Adv Neurol Disord."},{"issue":"8","key":"435_CR25","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3111\/13696998.2013.811079","volume":"16","author":"SL Shingler","year":"2013","unstructured":"Shingler SL, Swinburn P, Ali S, Perard R, Lloyd AJ. A discrete choice experiment to determine patient preferences for injection devices in multiple sclerosis. J Med Econ. 2013;16(8):1036\u201342.","journal-title":"J Med Econ."},{"issue":"6","key":"435_CR26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1756285614555335","volume":"7","author":"KS Utz","year":"2014","unstructured":"Utz KS, Hoog J, Wentrup A, Berg S, Lammer A, Jainsch B, et al. Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis. Ther Adv Neurol Disord. 2014;7(6):263\u201375.","journal-title":"Ther Adv Neurol Disord."},{"issue":"1","key":"435_CR27","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2196\/ijmr.3776","volume":"4","author":"P Wicks","year":"2015","unstructured":"Wicks P, Brandes D, Park J, Liakhovitski D, Koudinova T, Sasane R. Preferred features of oral treatments and predictors of non-adherence: two web-based choice experiments in multiple sclerosis patients. Interact J Med Res. 2015;4(1):e6.","journal-title":"Interact J Med Res."},{"issue":"2","key":"435_CR28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.7224\/1537-2073.2013-053","volume":"17","author":"LS Wilson","year":"2015","unstructured":"Wilson LS, Loucks A, Gipson G, Zhong L, Bui C, Miller E, et al. Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis. Int J MS Care. 2015;17(2):74\u201382.","journal-title":"Int J MS Care."},{"issue":"5","key":"435_CR29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jval.2013.04.005","volume":"16","author":"PJ Lin","year":"2013","unstructured":"Lin PJ, Cangelosi MJ, Lee DW, Neumann PJ. Willingness to pay for diagnostic technologies: a review of the contingent valuation literature. Value Health. 2013;16(5):797\u2013805.","journal-title":"Value Health."},{"key":"435_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the economic evaluation of health care programs","author":"MF Drummond","year":"2005","unstructured":"Drummond MF, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL. Contingent valuation studies. Methods for the economic evaluation of health care programs. 3rd ed. Oxford: Oxford University Press; 2005. p. 219\u201320.","edition":"3"},{"key":"435_CR31","doi-asserted-by":"crossref","unstructured":"Desvousges WH, Johnson FR, Dunford RW, Boyle KJ, Hudson SP, Wilson KN. Measuring nonuse damages using contingent valuation: an experimental evaluation of accuracy. 2nd ed. RTI Press publication No. BK-0001-1009. Research Triangle Park, NC: RTI International; 2010. http:\/\/www.rti.org\/rtipress . Accessed 1 Nov 2015.","DOI":"10.3768\/rtipress.2009.bk.0001.1009"},{"issue":"3","key":"435_CR32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hec.1704","volume":"21","author":"PJ Neumann","year":"2012","unstructured":"Neumann PJ, Cohen JT, Hammitt JK, Concannon TW, Auerbach HR, Fang C, et al. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ. 2012;21(3):238\u201351.","journal-title":"Health Econ"},{"issue":"9","key":"435_CR33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","volume":"366","author":"MJ Barry","year":"2012","unstructured":"Barry MJ, Edgman-Levitan S. Shared decision making\u2013pinnacle of patient-centered care. N Engl J Med. 2012;366(9):780\u20131.","journal-title":"N Engl J Med."},{"issue":"8","key":"435_CR34","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1377\/hlthaff.2009.0888","volume":"29","author":"RM Epstein","year":"2010","unstructured":"Epstein RM, Fiscella K, Lesser CS, Stange KC. Why the nation needs a policy push on patient-centered health care. Health affairs (Proj Hope). 2010;29(8):1489\u201395.","journal-title":"Health affairs (Proj Hope)."},{"issue":"6","key":"435_CR35","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.juro.2007.03.003","volume":"177","author":"I Thompson","year":"2007","unstructured":"Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106\u201331.","journal-title":"J Urol."},{"issue":"26","key":"435_CR36","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMp1504245","volume":"372","author":"PA Ubel","year":"2015","unstructured":"Ubel PA. Medical facts versus value judgments\u2013toward preference-sensitive guidelines. N Engl J Med. 2015;372(26):2475\u20137.","journal-title":"N Engl J Med."},{"issue":"3","key":"435_CR37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1377\/hlthaff.26.3.761","volume":"26","author":"SJ Katz","year":"2007","unstructured":"Katz SJ, Hawley ST. From policy to patients and back: surgical treatment decision making for patients with breast cancer. Health Affairs (Proj Hope). 2007;26(3):761\u20139.","journal-title":"Health Affairs (Proj Hope)."},{"issue":"7414","key":"435_CR38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/bmj.327.7414.542","volume":"327","author":"RE Say","year":"2003","unstructured":"Say RE, Thomson R. The importance of patient preferences in treatment decisions\u2013challenges for doctors. BMJ (Clin Res Ed). 2003;327(7414):542\u20135.","journal-title":"BMJ (Clin Res Ed)."},{"issue":"11","key":"435_CR39","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444\u201352.","journal-title":"Neurology."},{"issue":"4","key":"435_CR40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.0.CO;2-B","volume":"7","author":"A Diener","year":"1998","unstructured":"Diener A, O\u2019Brien B, Gafni A. Health care contingent valuation studies: a review and classification of the literature. Health Econ. 1998;7(4):313\u201326.","journal-title":"Health Econ"},{"issue":"9","key":"435_CR41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40273-014-0170-x","volume":"32","author":"MD Clark","year":"2014","unstructured":"Clark MD, Determann D, Petrou S, Moro D, de Bekker-Grob EW. Discrete choice experiments in health economics: a review of the literature. PharmacoEconomics. 2014;32(9):883\u2013902.","journal-title":"PharmacoEconomics."},{"issue":"1","key":"435_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13561-015-0077-z","volume":"6","author":"AC Muhlbacher","year":"2015","unstructured":"Muhlbacher AC, Zweifel P, Kaczynski A, Johnson FR. Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues. Health Econ Rev. 2015;6(1):5.","journal-title":"Health Econ Rev."},{"key":"435_CR43","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in health and medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LB, Weinstein MCE. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996."}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-016-0435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40273-016-0435-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-016-0435-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T12:41:01Z","timestamp":1718714461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40273-016-0435-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1007\/s40273-016-0435-7","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"type":"print","value":"1170-7690"},{"type":"electronic","value":"1179-2027"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}